Skip to main content
Applied Biological Chemistry
Fig. 3 | Applied Biological Chemistry

Fig. 3

From: Metabolomics reveals that Curcuma longa and demethoxycurcumin inhibit HCT116 human colon cancer cell growth

Fig. 3

Multivariate statistical analyses of NMR data. A PCA score plot of control group, doxorubicin treatment group and C. longa extract treatment group (R2X = 0.875, Q2 = 0.722), B OPLS-DA score plot of control group and C. longa extract treatment group (R2X = 0.531, R2Y = 0.995, Q2 = 0.983), C OPLS-DA S-line plot of control group and C. longa extract treatment group, D PCA score plot of control group, doxorubicin treatment group and demethoxycurcumin treatment (20, 40, 60 µM) groups (R2X = 0.241, Q2 = 0.15), E OPLS-DA score plot of control group and demethoxycurcumin 60 µM treatment group (R2X = 0.383, R2Y = 0.997, Q2 = 0.928), F OPLS-DA S-line plot of control group and demethoxycurcumin 60 µM treatment group

Back to article page